EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Aflibercept (excluding 114.3 mg/ml), ATC S01LA05 for the period 01.12.2025 - 30.11.2027
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Aflibercept (ausgenommen 114,3 mg/ml), ATC S01LA05 für die Zeit 01.12.2025 - 30.11.2027
EU-wide public tender in Germany: “Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active ingredient Aflibercept (excluding 114.3 mg/ml), ATC S01LA05 for the period 01.12.2025 - 30.11.2027”. Offers are due by Tuesday, 5 October 2027, in 338 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 October 2027, 338 days left, 12:00
- Published
- 17 October 2025
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
DAK-Gesundheit concludes a discount agreement for the active ingredient Aflibercept.
- The contract term is from 1 December 2025 to 30 November 2027.
- Pharmaceutical companies can join at any time under the same conditions.
- The complete documents must be submitted by email.
- Joining requires submission by the 5th of the preceding month.
- The procedure ends upon conclusion of a later exclusive contract.
Summary made from the German notice and checked against it; the German original is authoritative.
What stands out
The contract runs for 24 months. The notice links the tender documents directly.
Deadlines and dates
| Published | Friday, 17 October 2025 |
|---|---|
| Deadline | Tuesday, 5 October 2027, 12:00 |
| Tender validity ends (calculated) | Thursday, 4 November 2027 |
Conditions stated in the notice
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Questions and answers
How much time is left to bid?
Until Tuesday, 5 October 2027, 338 days left. The exact time and how to submit are in the original notice, which is authoritative.
In which language are the documents and the offer?
Usually German. The notice states the accepted languages; translations of supporting documents may be requested.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
Can a company from another EU country bid?
Yes. This tender is published EU-wide, and above the EU thresholds the EU directives guarantee companies from every member state equal treatment. You submit on the platform named in the notice after registering there.
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.